Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2401707rdf:typepubmed:Citationlld:pubmed
pubmed-article:2401707lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0030095lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0029260lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:2401707lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:2401707pubmed:issue4lld:pubmed
pubmed-article:2401707pubmed:dateCreated1990-10-23lld:pubmed
pubmed-article:2401707pubmed:abstractTextWe examined the effect of naloxone on plasma oxytocin levels during sexual activity in men. Eight normal men took part in a double-blind, two-period, cross-over design. Mean plasma oxytocin rose to 362% of baseline values at orgasm with placebo (saline) but showed no increase with naloxone (P less than 0.01). While naloxone had no effect on heart rate or blood pressure at orgasm, a decrease in the level of subjective arousal and pleasure at orgasm was noted. We conclude that opioid receptor blockade with naloxone has an inhibitory effect on the neural pathways mediating the oxytocin response at orgasm.lld:pubmed
pubmed-article:2401707pubmed:languageenglld:pubmed
pubmed-article:2401707pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2401707pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2401707pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2401707pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2401707pubmed:statusMEDLINElld:pubmed
pubmed-article:2401707pubmed:monthOctlld:pubmed
pubmed-article:2401707pubmed:issn0021-972Xlld:pubmed
pubmed-article:2401707pubmed:authorpubmed-author:CheckleyS ASAlld:pubmed
pubmed-article:2401707pubmed:authorpubmed-author:LightmanS LSLlld:pubmed
pubmed-article:2401707pubmed:authorpubmed-author:MurphyM RMRlld:pubmed
pubmed-article:2401707pubmed:authorpubmed-author:SecklJ RJRlld:pubmed
pubmed-article:2401707pubmed:issnTypePrintlld:pubmed
pubmed-article:2401707pubmed:volume71lld:pubmed
pubmed-article:2401707pubmed:ownerNLMlld:pubmed
pubmed-article:2401707pubmed:authorsCompleteYlld:pubmed
pubmed-article:2401707pubmed:pagination1056-8lld:pubmed
pubmed-article:2401707pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:meshHeadingpubmed-meshheading:2401707-...lld:pubmed
pubmed-article:2401707pubmed:year1990lld:pubmed
pubmed-article:2401707pubmed:articleTitleNaloxone inhibits oxytocin release at orgasm in man.lld:pubmed
pubmed-article:2401707pubmed:affiliationInstitute of Psychiatry, De Crespigny Park, Denmark Hill, London, England.lld:pubmed
pubmed-article:2401707pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2401707pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2401707pubmed:publicationTypeControlled Clinical Triallld:pubmed